Open access · CC-BY
via OpenAlex
Impact of COVID-19 and Antibiotic Treatments on Gut Microbiome: A Role for Enterococcus spp.
Elda Righi, Lorenza Lambertenghi, Anna Górska, Concetta Sciammarella, Federico Ivaldi, Massimo Mirandola, Assunta Sartor, Evelina Tacconelli
Biomedicines · 2022 · ▲ 19 citations
Abstract
Objective: Several studies showed the substantial use of antibiotics and increased risk of antimicrobial resistant infections in patients with COVID-19. The impact of COVID-19-related treatments and antibiotics on gut dysbiosis has not been clarified. Design: The prospective cohort study included hospitalized COVID-19 patients (April–December 2020). The gut microbiome composition was analysed by 16S sequencing. The gut diversity and changes in opportunistic bacteria (OBs) or symbionts were analysed according to clinical parameters, laboratory markers of disease progression, type of non-antibiotic COVID-19 treatments (NACT) and type, WHO AWaRe group, and duration of antibiotic therapy (AT). Results: A total of 82 patients (mean age 66 ± 13 years, 70% males) were enrolled. The relative abundance of Enterococcus was significantly correlated with duration of hospitalization, intensive care unit stay, O2 needs, and D-dimer, ferritin, and IL-6 blood levels. The presence of Enterococcus showed the highest number of correlations with NACT, AT, and AT + NACT (e.g., hydroxychloroquine ± lopinavir/ritonavir) and increased relative abundance with AWaRe Watch/Reserve antibiotics, AT duration, and combinations. Abundance of Dorea, Agathobacter, Roseburia, and Barnesiella was negatively correlated with AT and corticosteroids use. Patients with increased IL-6, D-dimer, and ferritin levels receiving AT were more likely to show dysbiosis with increased abundance of Enterococcus and Bilophila bacteria and decreased abundance of Roseburia compared with those not receiving AT. Conclusion: Microbiome diversity is affected by COVID-19 severity. In this context, antibiotic treatment may shift the gut microbiome composition towards OBs, particularly Enterococcus. The impact of treatment-driven dysbiosis on OBs infections and long-term consequences needs further study to define the role of gut homeostasis in COVID-19 recovery and inform targeted interventions.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/biomedicines10112786
- Canonical
- link ↗
- Fetched
- 2026-11-11 MST
Cite this
APA
Righi, E., Lambertenghi, L., Górska, A., Sciammarella, C., Ivaldi, F., Mirandola, M., Sartor, A., & Tacconelli, E. (2022). Impact of COVID-19 and Antibiotic Treatments on Gut Microbiome: A Role for Enterococcus spp. <em>Biomedicines</em>. https://doi.org/10.3390/biomedicines10112786
Vancouver
Righi E, Lambertenghi L, Górska A, Sciammarella C, Ivaldi F, Mirandola M, et al. Impact of COVID-19 and Antibiotic Treatments on Gut Microbiome: A Role for Enterococcus spp. Biomedicines. 2022. doi:10.3390/biomedicines10112786.
BibTeX
@article{elda2022Impact,
title = {Impact of COVID-19 and Antibiotic Treatments on Gut Microbiome: A Role for Enterococcus spp.},
author = {Elda Righi and Lorenza Lambertenghi and Anna Górska and Concetta Sciammarella and Federico Ivaldi and Massimo Mirandola and Assunta Sartor and Evelina Tacconelli},
journal = {Biomedicines},
year = {2022},
doi = {10.3390/biomedicines10112786},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Fatima Jinnah Medical University 2022
Open access · CC-BY
Correlation of inflammatory biomarkers with disease severity in hospitalised patients of COVID-19 at presentation
Aging 2020
Open access · CC-BY
Biomarkers of biological age as predictors of COVID-19 disease severity
Springer eBooks 2026
Citation only
Gut Dysbiosis in Alzheimer’s Disease: Insights from the Microbiome
Ageing research reviews 2026
Citation only
Association between muscle fatigability, self-perceived fatigue and inflammation in older adults: A systematic literature review.
PLoS ONE 2023
Open access · CC-BY
Gut microbiome dysbiosis in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis
Clinical Gastroenterology and Hepatology 2008
Open access · OA